Phoenix Asia Swings to Loss, Gross Margin Collapses to 4.6%
PHOE has more than doubled off its 52-week low of $6.56.
Summary
Phoenix Asia swung to a $1.2M loss in FY2026 as gross margin collapsed to 4.6%. The filing also discloses a pending $1B pharma acquisition and a $20M convertible note to its controlling shareholder.
Key Events · Earnings and Guidance · PHOE
-
Net Loss of $1.2M
Phoenix Asia reported a net loss of $1,200,960 for FY2026, compared to net income of $1,026,318 in FY2025.
-
Gross Margin Collapse
Gross profit margin fell from 29.5% to 4.6%, driven by a 41.5% increase in subcontracting costs.
-
Material Weaknesses Persist
Management concluded internal controls over financial reporting remain ineffective as of March 31, 2026, citing four material weaknesses.
-
$1B Pharma Acquisition
Subsequent to year-end, the company agreed to acquire ACEA Pharma for 100 million newly issued shares valued at $1.0 billion.
Analysis · PHOE · Real Estate & Construction
Phoenix Asia reported a net loss of $1.2 million for fiscal 2026, a sharp reversal from a $1.0 million profit the prior year. The deterioration was driven by a collapse in gross margin from 29.5% to 4.6%, as subcontracting costs surged 41.5% while revenue slipped 2.2%. The company also disclosed that its internal controls over financial reporting remain ineffective, with four material weaknesses identified. Additionally, the filing reveals two major subsequent events: a $1 billion all-stock acquisition of a clinical-stage pharma company and a $20 million convertible note issued to its controlling shareholder. These developments fundamentally alter the company's risk profile and strategic direction.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PHOE was trading at $22.30 on NASDAQ in the Real Estate & Construction sector, with a market capitalization of approximately $481.7M. The 52-week trading range was $6.56 to $133.12. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.